Coexisting Morbidities in Heart Failure: No Robust Interaction with the Left Ventricular Ejection Fraction

Curr Heart Fail Rep. 2020 Aug;17(4):133-144. doi: 10.1007/s11897-020-00461-3.

Abstract

Purpose of review: Heart failure (HF) patients often present with multiple coexisting morbidities. In this review, we contend that coexisting morbidities are highly prevalent and clinically important regardless of the left ventricular ejection fraction (LVEF).

Recent findings: Multimorbidity is prevalent in the ambulatory subjects of the community and increases with age. Differences in the prevalence of coexisting morbidities between HF with preserved LVEF (> 50%), mid-range LVEF (40-50%), and reduced LVEF (< 40%) are either not demonstrable or whenever present are small and unrelated to morbidity and mortality. The constellation of coexisting morbidities together with the disease modifiers (age, sex, genes, other) defines the HF phenotype and outcome. There is no robust evidence supporting an interaction in HF patients between the prevalence and clinical significance of coexisting morbidities and the LVEF.

Keywords: Aging; Coexisting morbidities; Genes; Sex; Spectrum.

Publication types

  • Review

MeSH terms

  • Comorbidity
  • Global Health
  • Heart Failure / epidemiology*
  • Heart Failure / physiopathology
  • Humans
  • Prognosis
  • Risk Factors
  • Stroke Volume / physiology*
  • Ventricular Dysfunction, Left / epidemiology*
  • Ventricular Dysfunction, Left / physiopathology
  • Ventricular Function, Left